Keratoconjunctivitis
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tolerability Comparison of Flarex to Lotemax SM (NCT07588074) | Harrow Inc | 2021-05-01 |
| Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops (NCT03706443) | Ohio State University | 2018-12-05 |
| A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers (NCT03769454) | Panoptes Pharma GmbH | 2018-11-20 |
| Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis (NCT00567918) | Astellas Pharma Inc | 2004-05-01 |
| Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis (NCT00567762) | Astellas Pharma Inc | 2004-02-01 |
Track Keratoconjunctivitis automatically
Every clearance here is in the API, with alerts when new ones post.